Lihui Bai

ID: 1b83bea9-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Aflibercept IPR Updates

Big Molecule Watch · July 28, 2023

Samsung Bioepis Files Four IPR Petitions on Alexion Eculizumab Patents and One IPR Petition on a Janssen Ustekinumab Patent

Big Molecule Watch · June 23, 2023

Accord BioPharma Announces the Acceptance of BLA for HLX02 (a proposed trastuzumab biosimilar) by FDA

Big Molecule Watch · April 14, 2023

Biogen Launches BYOOVIZ (ranibizumab) in Canada

Big Molecule Watch · March 10, 2023

European Biosimilar Regulatory Updates

Big Molecule Watch · February 6, 2023